[ZLTQ] ZELTIQ Aesthetics, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 43.61 Change: 0.85 (1.99%)
Ext. hours: Change: 0 (0%)

chart ZLTQ

Refresh chart

Strongest Trends Summary For ZLTQ

ZLTQ is in the long-term up 870% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: ZELTIQ Aesthetics, Inc., a medical technology company, is engaged in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. The company sells its products through a network of distributors, as well as a direct sales force to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was founded in 2005 and is headquartered in Pleasanton, California.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 9.56% Sales Growth - Q/Q1.55% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA6.52% ROE9.77% ROI
Current Ratio2.71 Quick Ratio2.18 Long Term Debt/Equity Debt Ratio0.48
Gross Margin71.59% Operating Margin3.92% Net Profit Margin3.45% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-2.83 M Cash From Investing Activities4.1 M Cash From Operating Activities7.23 M Gross Profit46.31 M
Net Profit1.18 M Operating Profit1.65 M Total Assets118.71 M Total Current Assets104.02 M
Total Current Liabilities43.47 M Total Debt320 K Total Liabilities44.46 M Total Revenue64.43 M
Technical Data
High 52 week37.53 Low 52 week19.26 Last close29.34 Last change2.02%
RSI61.38 Average true range1.07 Beta1.4 Volume319.07 K
Simple moving average 20 days6.46% Simple moving average 50 days6.15% Simple moving average 200 days4.82%
Performance Data
Performance Week7.35% Performance Month-0.54% Performance Quart2.66% Performance Half8.75%
Performance Year6.77% Performance Year-to-date2.84% Volatility daily2.07% Volatility weekly4.62%
Volatility monthly9.47% Volatility yearly32.79% Relative Volume194.97% Average Volume689.28 K
New High16.2% New Low

News

2017-04-28 11:06:03 | IDEXX Laboratories IDXX Beats Q1 Earnings, Raises View

2017-04-28 10:55:02 | ResMed RMD Beats Q3 Earnings, Misses Sales Estimates

2017-04-28 09:37:01 | Abaxis ABAX Beats Q4 Earnings Estimates, Revenues In Line

2017-04-27 16:54:08 | Mead Johnson MJN Lags Q1 Earnings, Awaits Merger Closure

2017-04-27 15:44:07 | Zimmer Biomet ZBH Beats on Q1 Earnings, Lowers Guidance

2017-04-27 08:23:12 | Integra LifeSciences IART Misses Q1 Earnings, Retains View

2017-04-26 10:46:02 | Thermo Fisher TMO Tops Q1 Earnings, Sales, Raises Guidance

2017-04-26 10:18:02 | Illumina ILMN Posts In-line Earnings in Q1, Margins Down

2017-04-26 09:48:01 | Edwards Lifesciences EW Tops Q1 Earnings, Updates '17 View

2017-04-26 08:46:12 | NuVasive NUVA Beats on Q1 Earnings, Retains 2017 View

2017-04-25 17:58:00 | PBF Energy Set to Join S&P MidCap 400; Apollo Commercial Real Estate Finance and Waddell & Reed Financial to Join S&P SmallCap 600

2017-04-25 10:27:02 | LabCorp LH Tops Q1 Earnings, Misses on Sales, Tweaks View

2017-04-20 09:30:01 | Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne

2017-04-20 08:35:12 | Rockwell Medical RMTI Catches Eye: Stock Moves Up 12.1%

2017-04-19 07:42:11 | Create an Efficient Portfolio with 5 Top Stocks

2017-04-19 07:41:11 | GNC Holdings GNC Q1 Earnings & Revenues Top, Decline Y/Y

2017-04-13 15:01:07 | Boston Scientific's Emerging Markets Grow Amid Currency Woes

2017-04-13 08:57:12 | Align ALGN Upgraded to Buy on Invisalign System Prospects

2017-04-12 09:36:01 | Haemonetics' Plasma Group Strong, Blood Center Group a Drag

2017-04-11 16:17:08 | ResMed's Study Results for Central Sleep Apnea Hold Promise

2017-04-06 09:47:01 | Medtronic HVAD System Results Positive for Long-Term Therapy

2017-04-06 08:50:12 | IDEXX Laboratories' CAG Revenues Solid, Competition Rife

2017-04-06 08:00:00 | Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction

2017-04-05 11:44:03 | Walgreens Boots WBA Meets Q2 Earnings, Retains EPS View

2017-04-04 10:21:12 | SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against ZELTIQ Aesthetics, Inc.

2017-04-04 09:03:01 | Walgreens, Prime Form Central Specialty & Mail Service Company

2017-04-04 08:12:00 | CoolSculpting® and Debra Messing Partner to Inspire Confidence and Cool Moments

2017-04-03 09:03:01 | NuVasive Receives FDA 510k Clearance in Cervical Spine

2017-04-03 08:46:12 | Amedisys to Buy East Tennessee to Expand in Personal Care

2017-03-31 09:44:01 | Abbott's St Jude Buyout to Boost Business, Risks Remain

2017-03-30 09:47:01 | Genomic Health's GPS Predicts Metastatic Prostate Cancer

2017-03-30 09:13:01 | NuVasive NUVA Gets FDA 510k Clearance for CoRoent System

2017-03-30 08:49:00 | QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics

2017-03-24 19:01:00 | Lifshitz & Miller LLP Announces Investigation of Delta Natural Gas Company, Inc., DigitalGlobe, Inc., FBR & Co., FTD Companies, Inc., Inventure Foods, Inc., Netflix, Inc. Rentech, Inc. and ZELTIQ Aesthetics, Inc.

2017-03-24 12:02:35 | Allergan Hoovers Aesthetics Market; Can Hologic Play?

2017-03-15 16:38:30 | ZELTIQ AESTHETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events

2017-03-13 14:48:00 | INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders

2017-03-13 08:03:00 | ZELTIQ AESTHETICS ZLTQ SHAREHOLDER ALERT – Andrews & Springer LLC is Investigating ZELTIQ Aesthetics, Inc. for Potential Breaches of Fiduciary Duty

2017-03-09 12:19:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ZELTIQ Aesthetics, Inc. - ZLTQ

2017-03-07 11:44:52 | ZELTIQ Aesthetics, Inc. :ZLTQ-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017

2017-03-03 09:00:00 | ZELTIQ® Showcases CoolAdvantage Petite™ Applicator for the CoolSculpting® System at American Academy of Dermatology Annual Meeting

2017-03-01 17:48:55 | Zeltiq beats Street 4Q forecasts

2017-03-01 16:34:57 | ZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh

2017-03-01 16:17:51 | ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results

2017-03-01 08:59:01 | Hit ETFs & Stocks from the Top Sector of February

2017-02-22 07:30:07 | [$$] Gormley's Take: Body Beautification Is Sexy Business

2017-02-21 10:58:00 | Medtronic Earnings Rebound in Third Quarter, Shares Climb

2017-02-17 18:49:00 | SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of ZELTIQ Aesthetics, Inc. -ZLTQ

2017-02-16 15:28:00 | INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ZELTIQ Aesthetics, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

2017-02-15 16:36:12 | ZELTIQ AESTHETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa